BRAF V600E mutational load as a prognosis biomarker in malignant melanoma.
Analyzing the mutational load of driver mutations in melanoma could provide valuable information regarding its progression. We aimed at analyzing the heterogeneity of mutational load of BRAF V600E in biopsies of melanoma patients of different stages, and investigating its potential as a prognosis fa...
Main Authors: | Arrate Sevilla, M Celia Morales, Pilar A Ezkurra, Javier Rasero, Verónica Velasco, Goikoane Cancho-Galan, Ana Sánchez-Diez, Karmele Mujika, Cristina Penas, Isabel Smith, Aintzane Asumendi, Jesús M Cortés, Maria Dolores Boyano, Santos Alonso |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0230136 |
Similar Items
-
Serum markers improve current prediction of metastasis development in early‐stage melanoma patients: a machine learning‐based study
by: Filippo Mancuso, et al.
Published: (2020-08-01) -
The role of BRAF V600 mutation in melanoma
by: Ascierto Paolo A, et al.
Published: (2012-07-01) -
Immunohistochemical BRAF V600E Expression and Intratumor BRAF V600E Heterogeneity in Acral Melanoma: Implication in Melanoma-Specific Survival
by: Takamichi Ito, et al.
Published: (2020-03-01) -
Cell-Centric View of Apoptosis and Apoptotic Cell Death-Inducing Antitumoral Strategies
by: Maria Dolores Boyano, et al.
Published: (2011-03-01) -
Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated
by: Muna Al Hashmi, et al.
Published: (2020-05-01)